BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15518636)

  • 1. Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.
    Seltzer A; Bregonzio C; Armando I; Baiardi G; Saavedra JM
    Brain Res; 2004 Nov; 1028(1):9-18. PubMed ID: 15518636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding.
    Saavedra JM; Armando I; Bregonzio C; Juorio A; Macova M; Pavel J; Sanchez-Lemus E
    Neuropsychopharmacology; 2006 Jun; 31(6):1123-34. PubMed ID: 16205776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury.
    Bregonzio C; Armando I; Ando H; Jezova M; Baiardi G; Saavedra JM
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G414-23. PubMed ID: 12686508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats.
    Bregonzio C; Seltzer A; Armando I; Pavel J; Saavedra JM
    Stress; 2008 Nov; 11(6):457-66. PubMed ID: 18609298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats.
    Gohlke P; Kox T; Jürgensen T; von Kügelgen S; Rascher W; Unger T; Culman J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):477-83. PubMed ID: 12070762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.
    Macova M; Pavel J; Saavedra JM
    Brain Res; 2009 Jan; 1250():130-40. PubMed ID: 19038235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II AT1 receptor blockade prevents gastric ulcers during cold-restraint stress.
    Bregonzio C; Armando I; Ando H; Jezova M; Baiardi G; Saavedra JM
    Ann N Y Acad Sci; 2004 Jun; 1018():351-5. PubMed ID: 15240390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress.
    Armando I; Carranza A; Nishimura Y; Hoe KL; Barontini M; Terrón JA; Falcón-Neri A; Ito T; Juorio AV; Saavedra JM
    Endocrinology; 2001 Sep; 142(9):3880-9. PubMed ID: 11517166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
    Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
    J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic-pituitary-adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: preliminary results.
    Pavlatou MG; Mastorakos G; Lekakis I; Liatis S; Vamvakou G; Zoumakis E; Papassotiriou I; Rabavilas AD; Katsilambros N; Chrousos GP
    Stress; 2008 Jan; 11(1):62-72. PubMed ID: 17853061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats.
    Gohlke P; Von Kügelgen S; Jürgensen T; Kox T; Rascher W; Culman J; Unger T
    J Hypertens; 2002 May; 20(5):909-18. PubMed ID: 12011652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
    Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G
    Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II: multitasking in the brain.
    Saavedra JM; Benicky J; Zhou J
    J Hypertens Suppl; 2006 Mar; 24(1):S131-7. PubMed ID: 16601566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress-induced release of catecholamines, glucocorticoids, and vasopressin.
    Baiardi G; Bregonzio C; Jezova M; Armando I; Saavedra JM
    Ann N Y Acad Sci; 2004 Jun; 1018():131-6. PubMed ID: 15240361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain.
    Ando H; Jezova M; Zhou J; Saavedra JM
    Ann N Y Acad Sci; 2004 Jun; 1018():345-50. PubMed ID: 15240389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.